{"title":"Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer.","authors":"Nivedita Chakrabarty, Abhishek Mahajan, Nitin Shetty, Naveen Mummudi, Devyani Niyogi, Falguni Hota, Deepak Dabkara, Reefath Jebraj, Nilendu Purandare, Vanita Noronha, Ashu Bhalla, Kumar Prabhash","doi":"10.1093/bjro/tzaf013","DOIUrl":null,"url":null,"abstract":"<p><p>Lung cancer is the second most commonly diagnosed cancer worldwide. In the present era of targeted therapy for various lung cancer mutations, it is essential to be aware of the imaging correlates of various lung cancer mutations on contrast enhanced computed tomography of thorax. In this article, we have discussed the imaging patterns of various types of lung cancer including different mutations and also comprehensively reviewed the imaging recommendations (National Comprehensive Cancer Network [NCCN], European Society of Medical Oncology [ESMO] and American Society of Clinical Oncology [ASCO]) and management guidelines of lung cancer (non-small cell, small cell and other neuroendocrine tumours). We have also discussed guidelines for screening, diagnosis, staging (recent 9th edition tumour node metastasis [TNM]), treatment response evaluation, and follow up. Role of interventional radiology in the treatment of primary lung cancer, lung metastasis, and management of posttreatment complications, have also been described in detail in this article. In addition, current status of artificial intelligence in lung cancer has also been briefly discussed.</p>","PeriodicalId":72419,"journal":{"name":"BJR open","volume":"7 1","pages":"tzaf013"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145177/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJR open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjro/tzaf013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Lung cancer is the second most commonly diagnosed cancer worldwide. In the present era of targeted therapy for various lung cancer mutations, it is essential to be aware of the imaging correlates of various lung cancer mutations on contrast enhanced computed tomography of thorax. In this article, we have discussed the imaging patterns of various types of lung cancer including different mutations and also comprehensively reviewed the imaging recommendations (National Comprehensive Cancer Network [NCCN], European Society of Medical Oncology [ESMO] and American Society of Clinical Oncology [ASCO]) and management guidelines of lung cancer (non-small cell, small cell and other neuroendocrine tumours). We have also discussed guidelines for screening, diagnosis, staging (recent 9th edition tumour node metastasis [TNM]), treatment response evaluation, and follow up. Role of interventional radiology in the treatment of primary lung cancer, lung metastasis, and management of posttreatment complications, have also been described in detail in this article. In addition, current status of artificial intelligence in lung cancer has also been briefly discussed.
肺癌是世界上第二常见的癌症。在目前针对各种肺癌突变进行靶向治疗的时代,了解胸腔增强ct上各种肺癌突变的影像学相关性是至关重要的。在本文中,我们讨论了包括不同突变在内的各种类型肺癌的影像学模式,并全面回顾了美国国家综合癌症网络(National Comprehensive cancer Network, NCCN)、欧洲肿瘤医学学会(European Society of Medical Oncology, ESMO)和美国临床肿瘤学会(American Society of Clinical Oncology, ASCO)的影像学建议和肺癌(非小细胞、小细胞和其他神经内分泌肿瘤)的治疗指南。我们还讨论了筛查、诊断、分期(最近的第9版肿瘤淋巴结转移[TNM])、治疗反应评估和随访的指南。介入放射学在原发性肺癌的治疗、肺转移和治疗后并发症的处理中的作用也在本文中有详细的描述。此外,对人工智能在肺癌中的研究现状也进行了简要的探讨。